JP2024525669A5 - - Google Patents
Info
- Publication number
- JP2024525669A5 JP2024525669A5 JP2024501194A JP2024501194A JP2024525669A5 JP 2024525669 A5 JP2024525669 A5 JP 2024525669A5 JP 2024501194 A JP2024501194 A JP 2024501194A JP 2024501194 A JP2024501194 A JP 2024501194A JP 2024525669 A5 JP2024525669 A5 JP 2024525669A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- variant
- pharmaceutical composition
- acid substitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/069450 WO2023284947A1 (en) | 2021-07-13 | 2021-07-13 | Il1ra derived peptides for treatment of diabetic nephropathy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525669A JP2024525669A (ja) | 2024-07-12 |
| JP2024525669A5 true JP2024525669A5 (cg-RX-API-DMAC7.html) | 2024-07-23 |
| JP7839260B2 JP7839260B2 (ja) | 2026-04-01 |
Family
ID=76958978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501194A Active JP7839260B2 (ja) | 2021-07-13 | 2021-07-13 | 糖尿病性腎症の処置のためのｉｌ１ｒａ由来ペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240216464A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4351617B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7839260B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117642174A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021455992A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226176A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3026437T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023284947A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| KR101317045B1 (ko) * | 2002-09-06 | 2013-10-16 | 암젠 인코포레이티드 | 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체 |
| ES2600616T3 (es) * | 2011-03-14 | 2017-02-10 | Phlogo Aps | Antagonistas del receptor de la interleucina-1 |
| WO2017063657A1 (en) * | 2015-10-14 | 2017-04-20 | Phlogo Aps | Il1ra-derived peptide antagonist |
| WO2018022982A1 (en) * | 2016-07-29 | 2018-02-01 | Trustees Of Boston University | Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development |
-
2021
- 2021-07-13 JP JP2024501194A patent/JP7839260B2/ja active Active
- 2021-07-13 WO PCT/EP2021/069450 patent/WO2023284947A1/en not_active Ceased
- 2021-07-13 AU AU2021455992A patent/AU2021455992A1/en active Pending
- 2021-07-13 CA CA3226176A patent/CA3226176A1/en active Pending
- 2021-07-13 ES ES21742823T patent/ES3026437T3/es active Active
- 2021-07-13 EP EP21742823.4A patent/EP4351617B1/en active Active
- 2021-07-13 US US18/577,588 patent/US20240216464A1/en active Pending
- 2021-07-13 CN CN202180100484.5A patent/CN117642174A/zh active Pending